Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2018 Feb:28:120-127.
doi: 10.1016/j.ebiom.2017.12.029. Epub 2018 Jan 10.

A 30-Min Nucleic Acid Amplification Point-of-Care Test for Genital Chlamydia trachomatis Infection in Women: A Prospective, Multi-center Study of Diagnostic Accuracy

Affiliations
Multicenter Study

A 30-Min Nucleic Acid Amplification Point-of-Care Test for Genital Chlamydia trachomatis Infection in Women: A Prospective, Multi-center Study of Diagnostic Accuracy

E M Harding-Esch et al. EBioMedicine. 2018 Feb.

Abstract

Background: Rapid Point-Of-Care Tests for Chlamydia trachomatis (CT) may reduce onward transmission and reproductive sexual health (RSH) sequelae by reducing turnaround times between diagnosis and treatment. The io® single module system (Atlas Genetics Ltd.) runs clinical samples through a nucleic acid amplification test (NAAT)-based CT cartridge, delivering results in 30min.

Methods: Prospective diagnostic accuracy study of the io® CT-assay in four UK Genito-Urinary Medicine (GUM)/RSH clinics on additional-to-routine self-collected vulvovaginal swabs. Samples were tested "fresh" within 10days of collection, or "frozen" at -80°C for later testing. Participant characteristics were collected to assess risk factors associated with CT infection.

Results: CT prevalence was 7.2% (51/709) overall. Sensitivity, specificity, positive and negative predictive values of the io® CT assay were, respectively, 96.1% (95% Confidence Interval (CI): 86.5-99.5), 97.7% (95%CI: 96.3-98.7), 76.6% (95%CI: 64.3-86.2) and 99.7% (95%CI: 98.9-100). The only risk factor associated with CT infection was being a sexual contact of an individual with CT.

Conclusions: The io® CT-assay is a 30-min, fully automated, high-performing NAAT currently CE-marked for CT diagnosis in women, making it a highly promising diagnostic to enable specific treatment, initiation of partner notification and appropriately intensive health promotion at the point of care.

Keywords: Chlamydia trachomatis; Diagnostic accuracy; Performance evaluation; Point-of-care; Rapid test; Risk factor.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flow chart summarizing patient recruitment and sample collection results availability. CT, Chlamydia trachomatis; NAAT, Nucleic Acid Amplification Test. Flow diagram showing total number of eligible participants who consented to the study, ending with the total number of participants included in the final analyses. Samples were excluded where the participant did not meet the study eligibility criteria (n = 18); that did not have a clinic NAAT result available (n = 18), that were not tested on the io® CT assay (n = 16); or that had a final invalid result by the io® CT assay (n = 24).

Similar articles

Cited by

References

    1. Abbott Abbott RealTime CT/NG. [Online] 2010. https://www.molecular.abbott/sal/en-us/staticAssets/ctng-8l07-91-us-fina... Package Insert. Available from.
    1. Adams E.J., Ehrlich A., Turner K.M.E., Shah K. Mapping patient pathways and estimating resource use for point of care versus standard testing and treatment of chlamydia and gonorrhoea in genitourinary medicine clinics in the UK. BMJ Open. [Online] 2014;4(7):e005322. - PMC - PubMed
    1. Aghaizu A., Reid F., Kerry S., Hay P.E. Frequency and risk factors for incident and redetected Chlamydia trachomatis infection in sexually active, young, multi-ethnic women: a community based cohort study. Sex. Transm. Infect. [Online] 2014;90(7):524–528. - PMC - PubMed
    1. Alonzo T.A., Pepe M.S. Using a combination of reference tests to assess the accuracy of a new diagnostic test. Stat. Med. [Online] 1999;18(22):2987–3003. http://www.ncbi.nlm.nih.gov/pubmed/10544302 Available from. - PubMed
    1. Atkinson L.M., Vijeratnam D., Mani R., Patel R. ‘The waiting game’: are current chlamydia and gonorrhoea near-patient/point-of-care tests acceptable to service users and will they impact on treatment? Int. J. of STD & AIDS. [Online] 2016;27(8):650–655. - PubMed

Publication types